AFP6h
European Commission Approves the Extension of the Indication of Palforzia® to the Treatment of Toddlers With Confirmed Peanut Allergy
Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
Pharmaceutical Technology5h
Palforzia’s peanut allergy treatment use in Europe expanded to toddlers
The EC has approved the extension of Stallergenes Greer’s Palforzia for the treatment of peanut allergy in toddlers.
Peninsula Daily News19h
VisiDefend Side Effects and Risks: Is It Safe for Long-Term Use?
Maintaining optimal eye health has become more crucial in today’s fast-paced world. With the rise of digital screens and ...